More importantly, it has also been demonstrated that up-regulation of HNF1α significantly suppressed the malignant phenotypes of HCC cells and induced the transformation of HCC cells into normal hepatocytes [18, 20], suggesting reverse the downtrend of HNF1α is a potential strategy for HCC therapy. Here, HNF1A is linked to hepatocellular carcinoma.